TLXTelix Pharmaceuticals Ltd
- Market cap
- $3.10B
- as of 2026-10-23
- Latest close
- $9.15
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-04-01
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Smith Darren CharltonGroup Chief Financial Officer | Sep 7 | Sep 14 | P | 2,071 | $9.66 | Purchase +$20,006 | 13,992 | No | Form 4 |
| Behrenbruch ChristianMD & Group CEO | Apr 29 | May 6 | P | 33,435 | $14.87 | Purchase +$497,178 | 20,742,935 | No | Form 4 |
| Behrenbruch ChristianMD & Group CEO | Apr 28 | May 6 | P | 34,500 | $14.48 | Purchase +$499,560 | 20,709,500 | No | Form 4 |
| Smith Darren CharltonGroup Chief Financial Officer | Mar 29 | Apr 1 | M | 1,111 | $0.00 | $0 | 11,921 | No | Form 4 |
| Smith Darren CharltonGroup Chief Financial Officer | Mar 29 | Apr 1 | M · derivative | 1,111 | $0.00 | $0 | not reported | No | Form 4 |